Home > Boards > US OTC > Medical - Drugs > Bioelectronics Corp. (BIEL)

Let’s be blunt: Q1 numbers are horrific.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
luke5516 Member Profile
 
Followed By 2
Posts 381
Boards Moderated 0
Alias Born 01/29/11
160x600 placeholder
luke5516   Monday, 05/20/19 09:02:56 PM
Re: None
Post # of 201208 
Let’s be blunt: Q1 numbers are horrific. Even worse than I expected and I wasn’t expecting much. The only positive there is the same amount of deferred revenue.

It’s hard to understand how we are making less money after the US clearances than we were before internationally.

While many companies get in trouble for inflating their quarterly numbers by cooking the books, it’s almost like the opposite is happening here.

Hard to understand how the numbers could be this bad in the midst of CVS rollout and modest expansion.

I’m not going anywhere, but I’m at a loss to explain how this company’s doing so poorly.

The buck stops at the CEO, President and Chairman of the Board - our Andy Whelan.

Bring back Ed Staelin for god sakes or sell this company to the highest bidder and end our misery.

It’s almost comical now. I’d laugh if I hadn’t poured thousands into it.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist